Revenue: The sum of all revenue fields included for a company's operating activities.
Mersana Therapeutics, Inc. (MRSN) had Revenue of $40.50M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$40.50M |
$-69.19M |
|
-- |
|
$40.50M |
|
$113.83M |
|
$-73.34M |
|
$4.56M |
|
$-68.77M |
|
$-68.77M |
|
$-69.19M |
|
$-69.19M |
|
$-69.19M |
|
$-69.19M |
|
$-73.34M |
|
$-75.62M |
|
122.54M |
|
122.54M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$136.90M |
|
$2.20M |
|
$7.76M |
|
$144.66M |
|
$62.46M |
|
$10.95M |
|
$91.71M |
|
$154.17M |
|
$-9.51M |
|
$-9.51M |
|
$-9.51M |
|
115.65M |
|
| Cash Flow Statement Financials | |
$-82.34M |
|
$11.44M |
|
$4.09M |
|
$175.04M |
|
$108.23M |
|
$-66.81M |
|
$16.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.19 |
|
-- |
|
-- |
|
7.60 |
|
-2.47 |
|
100.00% |
|
-181.09% |
|
-181.09% |
|
-186.74% |
|
-169.82% |
|
-170.86% |
|
$-82.47M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
-- |
|
-- |
|
-- |
|
727.65% |
|
727.65% |
|
-47.83% |
|
-4801.67% |
|
$-0.08 |
|
$-0.67 |
|
$-0.67 |
|